BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19286155)

  • 1. Biochemistry, genetics and therapy of malignant pheochromocytomas.
    Mannelli M
    Ann Endocrinol (Paris); 2009 Jun; 70(3):166-7. PubMed ID: 19286155
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytoma.
    Rich TA; Jonasch E; Matin S; Waguespack SG; Gombos DS; Santarpia L; Stolle C; Jimenez C
    Cancer Invest; 2008 Jul; 26(6):642-6. PubMed ID: 18584357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extremely low risk of pheochromocytomas in complete VHL gene deletion cases.
    Janavicius R; Adomaitis R; Jankevicius F; Griskevicius L
    Hum Mutat; 2009 Sep; 30(9):1365-6; author reply 1367. PubMed ID: 19623534
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bilateral pheochromocytoma. Genetics and treatment].
    Mirallié E; Cariou B; Kraeber-Bodéré F
    Ann Chir; 2005 Apr; 130(4):273-6. PubMed ID: 15847867
    [No Abstract]   [Full Text] [Related]  

  • 5. von Hippel-Lindau gene mutation in non-syndromic familial pheochromocytomas.
    Tong AL; Zeng ZP; Li HZ; Yang D; Lu L; Li M; Zhou YR; Zhang J; Chen S; Liang W
    Ann N Y Acad Sci; 2006 Aug; 1073():203-7. PubMed ID: 17102088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three novel VHL germline mutations in Korean patients with von Hippel-Lindau disease and pheochromocytomas.
    Kang HC; Kim IJ; Park JH; Shin Y; Jang SG; Ahn SA; Park HW; Lim SK; Oh SK; Kim DJ; Lee KW; Choi YS; Park YJ; Lee MR; Kim DW; Park JG
    Oncol Rep; 2005 Oct; 14(4):879-83. PubMed ID: 16142346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
    Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
    Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathoracic and multiple abdominal pheochromocytomas in von Hippel-Lindau disease.
    Hoffman RW; Gardner DW; Mitchell FL
    Arch Intern Med; 1982 Oct; 142(10):1962-4. PubMed ID: 7125783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pheochromocytoma and paraganglioma: recent progress and new vistas for improved patient care.
    Eisenhofer G; Schott M; Bornstein S
    Horm Metab Res; 2012 May; 44(5):325-7. PubMed ID: 22566193
    [No Abstract]   [Full Text] [Related]  

  • 10. Familial isolated pheochromocytoma presenting a new mutation in the von Hippel-Lindau gene.
    Sansó G; Rudaz MC; Levin G; Barontini M
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1107-11. PubMed ID: 15607616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors.
    Jimenez C; Cabanillas ME; Santarpia L; Jonasch E; Kyle KL; Lano EA; Matin SF; Nunez RF; Perrier ND; Phan A; Rich TA; Shah B; Williams MD; Waguespack SG
    J Clin Endocrinol Metab; 2009 Feb; 94(2):386-91. PubMed ID: 19017755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pheochromocytoma.
    Brown MJ; Grossman AB; Bornstein SR
    Horm Metab Res; 2009 Sep; 41(9):655-7. PubMed ID: 19742403
    [No Abstract]   [Full Text] [Related]  

  • 13. Inherited pheochromocytoma.
    Neumann HP; Bender BU; Januszewicz A; Janetschek G; Eng C
    Adv Nephrol Necker Hosp; 1997; 27():361-76. PubMed ID: 9408456
    [No Abstract]   [Full Text] [Related]  

  • 14. [Von Hippel-Lindau disease].
    Takahashi K; Iida K; Chihara K
    Nihon Rinsho; 2006 Sep; Suppl 3():351-4. PubMed ID: 17022562
    [No Abstract]   [Full Text] [Related]  

  • 15. Transcription association of VHL and SDH mutations link hypoxia and oxidoreductase signals in pheochromocytomas.
    Dahia PL;
    Ann N Y Acad Sci; 2006 Aug; 1073():208-20. PubMed ID: 17102089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pheochromocytoma: implications in tumorigenesis and the actual management.
    Shah U; Giubellino A; Pacak K
    Minerva Endocrinol; 2012 Jun; 37(2):141-56. PubMed ID: 22691888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
    Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G
    N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary pheochromocytoma and paraganglioma.
    Mazzaglia PJ
    J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of pheochromocytomas and paragangliomas.
    Opocher G; Schiavi F
    Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):943-56. PubMed ID: 21115163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Familial pheochromocytoma].
    Tamura N; Nakao K
    Nihon Rinsho; 2006 May; Suppl 1():730-4. PubMed ID: 16776261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.